Key result
African ancestry locus 6q25.3 linked to ~367% higher CKD risk in U.S. Hispanic/Latino individuals.
Why the study?
Ancestry-specific factors may contribute to CKD risk in Central America, but the genetic ancestry influences on CKD susceptibility are not well understood.
Cohort (n=1,023)
Yes
Odds Ratio: 4.67 (95% CI 2.1–10.4)
p-value: p=1.62x10-4
Admixture mapping in U.S. Hispanic/Latino individuals of Central American descent identified novel ancestry-specific genetic loci associated with CKD, albuminuria, and type 2 diabetes.
May inform ancestry-specific CKD risk assessment in Central American Hispanics; leaves open validation and clinical utility pending prospective studies.
Chronic kidney disease (CKD) is prevalent in Central America and ancestry-specific factors may contribute to CKD risk. To understand the genetic ancestry influences on CKD susceptibility, we conducted an admixture mapping of CKD traits and risk factors on 1,023 participants of the Hispanic Community Health Study/Study of Latinos who reported four-grandparents originating from the same Central America country. Admixture mapping signals were validated on 8,191 African Americans from the Women’s Health Initiative, 3,141 American Indians from the Strong Heart Study and 197,272 White individuals from the Million Veterans Program. We identified five novel ancestry-derived loci on chromosomes: 14 for albuminuria; 2, 6 and 9 for CKD; and 3 for type 2 diabetes (T2D). The 14q24.2 locus was validated in American Indians and consisted of two regions spanning the RGS6 gene, in which the European (risk) and Native American (protective) ancestries had opposite effects for albuminuria. This locus was also identified using the traditional association mapping. Among the three CKD loci, the 6q25.3 African ancestry-derived locus at ARID1B gene, associated with increased risk for CKD, was validated in African Americans. The T2D locus at 3q22.2 encompasses the EPHB1 and KY genes and was validated in White individuals. U.S. Hispanic/Latino populations are culturally and genetically diverse. Our strategy of using grandparent country-of-origin for selection of a more genetically similar group likely helped the gene discovery. This study of CKD traits and risk factors in individuals from Central America country-of-origin provides new insights into the ancestry-of-origin influences on CKD in this population.
No takes yet. Share an insight, caveat, or question.
Horimoto et al. (2022) conducted a cohort in Chronic kidney disease (CKD) (n=1,023). African genetic ancestry at 6q25.3 locus vs. Other ancestries was evaluated on Chronic kidney disease (CKD) (OR 4.67, 95% CI 2.10-10.40, p=1.62x10-4). Admixture mapping in U.S. Hispanic/Latino individuals of Central American descent identified five novel ancestry-derived loci, including a 6q25.3 African ancestry locus associated with increased CKD risk (OR 4.67).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: